Oncology Pharmacy Education

A topical collection in Pharmacy (ISSN 2226-4787). This collection belongs to the section "Pharmacy Education and Student/Practitioner Training".

Viewed by 2121

Editor


E-Mail Website
Guest Editor
School of Pharmacy, Department of Clinical Pharmacy, Touro University California, Mare Island Vallejo, CA 94592, USA
Interests: oncology; oncology education; oncology workforce; supportive care
Special Issues, Collections and Topics in MDPI journals

Topical Collection Information

Dear Colleagues, 

Oncology has become a very active and important area of pharmacy practice. Despite the increasing demand for oncology pharmacists, there is a lack of adequate education being provided by pharmacy schools. We reported in 2015 that only 15% of pharmacy students took a required or an elective APPE oncology rotation (Curr Pharm Teach Learn (2015) 7: 451–457). In addition, on average only 30% of a class was exposed to an oncology experience (for an average class size of 100). Furthermore, the number of training programs for prospective oncology pharmacists (PGY2 programs) amounts to only about 200 per year, and the number of Board Certified Oncology Pharmacists in 2020 is only about 3600. Thus, the growth of trained oncology pharmacists is inadequate to meet the demand for patient care. How are you training your pharmacists to become effective oncology pharmacy practitioners? How many hours are being devoted to didactics and how many hours to practical? Do you employ testing to evaluate competency if a practitioner is not board certified? 

We invite you to submit a descriptive or objective study demonstrating an innovative approach to educating oncology pharmacy practitioners. We hope that this call for papers will inspire you to share your experiences and programs with us. 

Prof. Dr. Robert Ignoffo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Oncology
  • Pharmacy
  • Education
  • Students
  • Pharmacy residents
  • Oncology APPE

Published Papers (1 paper)

2024

9 pages, 512 KiB  
Brief Report
Pharmacists’ Behavioral Changes after Attending a Multi-Prefectural Palliative Care Education Program
by Masahiro Yamada, Mayako Uchida, Masao Hada, Haruka Wakabayashi, Daigo Inma, Shunji Ariyoshi, Hidetoshi Kamimura and Tohru Haraguchi
Pharmacy 2024, 12(3), 87; https://doi.org/10.3390/pharmacy12030087 - 4 Jun 2024
Viewed by 746
Abstract
Central to the pharmacist’s role in palliative care is symptom management through direct participation in patient care and the provision of optimal pharmacotherapy to support patient outcomes. Consequently, palliative care requires extensive knowledge and action for patients with cancer. Therefore, this study aimed [...] Read more.
Central to the pharmacist’s role in palliative care is symptom management through direct participation in patient care and the provision of optimal pharmacotherapy to support patient outcomes. Consequently, palliative care requires extensive knowledge and action for patients with cancer. Therefore, this study aimed to evaluate how pharmacists’ behavior changed after attending a palliative care educational program. We conducted a web-based questionnaire survey examining the behavior of pharmacists regarding palliative care before participating in the program, two months after participating in the program, and eight months after participating in the program to determine their behavior and changes over time. For all questions, scores were higher at two and eight months after attending the program than before attending the program (p < 0.05). In addition, no significant difference was observed between two and eight months after attending the program for any question (p = 0.504–1.000). The knowledge gained from the educational program was used to repeatedly intervene with patients with cancer in order to address the various symptoms they experienced and maintain their behavior. The proven effectiveness of this program serves as a stepping stone for nationwide rollout across Japan’s 47 prefectures. Full article
Show Figures

Figure 1

Back to TopTop